Page 109 - Read Online
P. 109

Page 12                   Melnik et al. J Transl Genet Genom 2022;6:1-45  https://dx.doi.org/10.20517/jtgg.2021.37

               the limit of detection. Several conjugated estrogen metabolites were identified: 17β-E2-3-glucuronide (71-
               289 ng/L), E1-3-sulfate (60-240 ng/L), 17β-E2-3,17β-sulfate (< LOD to 30 ng/L), and E3-glucuronide (<
                             [376]
               LOD of 25 ng/L) . Thus, endogenous and exogenous steroids derived from dairy products produced from
                                                                      [377]
               whole milk are a source of exogenous steroid exposure to humans .

               Obesity has been proposed to be involved in the pathogenesis and more aggressive courses of PCa [378,379] .
               Notably, a twofold elevation of serum E1 and 17β-E2 levels was observed in a group of morbidly obese
               men . Thus, obese men with increased endogenous estrogen production may represent a vulnerable
                   [380]
               group, especially during further exogenous estrogen exposure derived from milk and dairy products. There
               is recent concern that estrogens represent an under-recognized contributor in PCa development and
               progression [381,382] . Of notice, AR and ERα expression changes during PCa progression, both independently
                              [383]
               and co-expressed . In high-grade prostatic intraepithelial neoplasia specimens (epithelium and stroma),
               an increase in the population of double-positive (AR /ERα ) cells has been observed, whereas double-
                                                                   +
                                                              +
                          -
                               -
               negative (AR /ERα ) cells significantly decreased in advanced PCa, from 65% in benign prostate tissue to
               30% in metastasis tissue .
                                   [383]
               There is extensive crosstalk among estrogens, androgens, and IGF-1 signaling in PCa cells. In LNCaP and
               PC3 cells, E1 increased the level of AR and IGF-1 expression [384,385] . The upregulation of ERα and estrogen-
               regulated progesterone receptor (PR) during PCa progression and hormone-refractory PCa suggests that
               estrogens and progestins stimulate tumor growth . A potentially aggressive molecular subtype of PCa
                                                          [386]
               exhibiting TMPRSS2-ERG gene fusion is regulated by ER. TMPRSS2-ERG expression increased by ERα
               agonist but decreased by ERβ agonists . Thus, increasing evidence demonstrates that local estrogens
                                                 [386]
               contribute to prostate carcinogenesis and tumor progression . It has also been reported in breast and
                                                                    [387]
               renal carcinoma cells that estrogens and IGF-1 have synergistic effects on tumor cell growth [388-391] . In fact,
               IGF1R expression in PCa is upregulated by both androgens and estrogens sensitizing PCa cells to the
                                      [392]
               mitogenic effects of IGF-1 . Of note, mTORC1 has been identified as a critical checkpoint for estrogen
               signaling . The downstream effector of mTORC1, the ribosomal S6K1, activates ERα via phosphorylation
                       [393]
               of S167. ERα binding to Raptor promotes its translocation into the nucleus upon estrogen stimulation. In
               addition, phosphorylation of ERα on S104/106 by mTOR kinase activates transcription of ER target
                    [394]
               genes . The molecular crosstalk between mTORC1 and ERα in the pathogenesis of PCa may be
               augmented by milk-mediated estrogens and milk-induced IGF-1, which synergistically activate mTORC1.
               Treatment of LNCaP cells with androgen or E2 triggers simultaneous association of AR and ERβ with SRC
               oncogene, activates the SRC/RAF-1/ERK-2 pathway, and stimulates cell proliferation . It has been
                                                                                            [394]
               demonstrated in cortical neurons that ER protein interaction with p85, the regulatory unit of PI3K, leads to
                                         [395]
               activation of AKT and ERK1/2 . PCa stem cells lack AR explaining the resistance to androgen deprivation
               therapy . However, PCa stem cells express classical (α and/or  β) and novel (GPR30) ERs . Gene
                      [396]
                                                                                                  [396]
               expression profiles of CD133+ 4/CD44+ PCa stem cells showed that many ribosomal proteins and
               translation initiation factors that constitute the mTOR complex were highly expressed .
                                                                                       [62]
               Galactose
               The lactose content of milk makes up around 2%-8% by weight. Lactose hydrolysis provides glucose and
               galactose, which both activate mTORC1. The great majority of men in Western societies consuming milk
               and dairy products is lactose-tolerant and can hydrolyze the disaccharide lactose into glucose and galactose.
               The total galactose content of bovine milk is 2.4 g/100 g . Increased sugar consumption from sweetened
                                                               [397]
               beverages was associated with increased risk of PCa for men in the highest quartile of sugar consumption
               (HR = 1.21, 95%CI: 1.06-1.39), and there was a linear trend (P < 0.01) . In adults, hepatic galactose
                                                                              [398]
               elimination capacity is related to body weight and decreases slowly with age [399,400] . Notably, galactose
   104   105   106   107   108   109   110   111   112   113   114